Story perspectives

Breakthrough Antibody Neutralizes 98% of HIV Variants

10/16/2025

Summary

Story summary

Researchers at the University Hospital of Cologne identified the antibody 04_A06, which neutralized 98% of tested HIV variants in laboratory experiments.
It blocks the virus from entering cells, offering a potential method of passive immunization.
04_A06 could provide an alternative with similar dosing schedules to lenacapavir and cabotegravir.
Further studies are needed to assess its efficacy in real-world scenarios.
Funding for HIV research is declining, raising concerns about future advancements.

1 of 1

Story summary

Researchers at the University Hospital of Cologne identified the antibody 04_A06, which neutralized 98% of tested HIV variants in laboratory experiments.
It blocks the virus from entering cells, offering a potential method of passive immunization.
04_A06 could provide an alternative with similar dosing schedules to lenacapavir and cabotegravir.
Further studies are needed to assess its efficacy in real-world scenarios.
Funding for HIV research is declining, raising concerns about future advancements.